Rodolphe Clerval

Rodolphe Clerval

Company: Coave Therapeutics

Job title: CEO


AAV-ligand Conjugates, a New Capsid Platform For Improved Gene Therapy Delivery 11:30 am

AAV capsids from 1st and last generations limitations (efficiency and safety) are related to the nature of the capsid composition Chemical conjugation of AAV capsid alter dramatically the biology of AAV leading to improve bio distribution, transduction and immunological profile Chemical conjugation of AAV is a versatile and scalable new capsid technologyRead more

day: Track A - Day 1 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.